Centinel Spine announced the completion of the 5,000th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System.
This follows the milestone of the 2,500th case reported in September 2023.
prodisc C Vivo and prodisc C SK are part of Centinel Spine’s new Match-the-Disc System, made available in a limited release in 4Q22. Over 600 surgeons have used the new system, confirming the benefits of intraoperatively selecting the appropriate implant for each patient’s anatomy.
“The rapid uptake and repeat usage of the prodisc C Vivo and prodisc C SK Match-the-Disc system demonstrates the value optionality brings to surgeons,” observes Centinel Spine CEO Steve Murray. “This new cervical total disc system is built on the prodisc technology platform that has been proven over the last three decades, delivering a unique combination of innovation and proven long-term clinical performance.”
Centinel Spine announced the completion of the 5,000th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System.
This follows the milestone of the 2,500th case reported in September 2023.
prodisc C Vivo and prodisc C SK are part of Centinel Spine’s new Match-the-Disc System, made available in a limited release in 4Q22....
Centinel Spine announced the completion of the 5,000th case in the U.S. with the prodisc C Vivo and prodisc C SK Cervical TDR System.
This follows the milestone of the 2,500th case reported in September 2023.
prodisc C Vivo and prodisc C SK are part of Centinel Spine’s new Match-the-Disc System, made available in a limited release in 4Q22. Over 600 surgeons have used the new system, confirming the benefits of intraoperatively selecting the appropriate implant for each patient’s anatomy.
“The rapid uptake and repeat usage of the prodisc C Vivo and prodisc C SK Match-the-Disc system demonstrates the value optionality brings to surgeons,” observes Centinel Spine CEO Steve Murray. “This new cervical total disc system is built on the prodisc technology platform that has been proven over the last three decades, delivering a unique combination of innovation and proven long-term clinical performance.”
Copy to clipboard 
